NCT00457964View on ClinicalTrials.gov

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Tuberous SclerosisLymphangioleiomyomatosis

Interventions

DRUG

RAD001

5 and 10 mg/day or 30, 50, 70mg/week

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER